FC vs REGN
Franklin Covey Company (FC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Franklin Covey Company (FC) is a education & training services company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FC revenue for 2025-08-31 was $267.1M. Net income was $3.1M. Revenue was down 7.0% from 2024-08-31 to 2025-08-31. FC currently screens at market cap $264.0M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FC currently screens at market cap $264.0M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FC and REGN stock pages for the full models.
Not investment advice.